KLRD1 and glioblastoma: Representative dot blot analysis of CD56+/CD94+, CD3-/CD56+, CD56+/CD69+ and CD3-/CD69+ NK cell subsets of a healthy individual and a grade IV glioblastoma patient are shown in Figure 4F.